CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Oct. 28, 2022—Bio-Rad Laboratories has launched two Exact Diagnostics molecular controls. The CT/NG Positive Run Control is intended to be used with Chlamydia trachomatis and Neisseria gonorrhoeae molecular assays. The STI Negative Run Control monitors the absence of Chlamydia trachomatis and Neisseria gonorrhoeae in various molecular assays, the company says, and can be used to detect errors in laboratory testing procedures, including potential contamination events, while controlling for sample adequacy assessment. Both are external quality controls designed to be used with molecular assays to monitor intra- and inter-run performance.
Pages: 1 2